Advances in genetic sequencing diagnose Paralympic hopeful's rare condition

June 16, 2013
Researchers identify the single genetic mutation responsible for rare condition in UK Paracycling Champion, Tom Staniford. Credit: Tom Staniford

National Paracycling Champion Tom Staniford has an extremely rare condition which, until now, has puzzled his doctors. He is unable to store fat under his skin – yet has type 2 diabetes – and suffered hearing loss as a child. Now, thanks to advances in genome sequencing, an international research team led by the University of Exeter Medical School has identified Tom's condition and pinpointed the single genetic mutation that causes it.

As well as allowing a better understanding of Tom's condition, the discovery may have implications for his bid to participate in the Rio 2016 . He hopes this new diagnosis will allow him to be more accurately classified in paracycling competitions; a more accurate classification could help him become a world champion.

In a study published in today's Nature Genetics, researchers funded in part by the Wellcome Trust and the National Institute for Health Research have identified the genetic mutation behind MDP Syndrome, a condition thought to affect as few as eight people in the world, including 23-year-old Tom.

"In some ways, identifying the syndrome behind my symptoms shouldn't be important – a name is just a name, after all – but it is reassuring to know that there are other people with the condition and that we can lead relatively normal lives," says Tom Staniford. "What could prove crucial, though, is enabling me to be properly classified in competitions so that I am not competing at an unfair disadvantage against others. I hope to be able to compete for in the 2016 and this finding could make a real difference to my chances."

In 2011, Tom became the youngest solo cyclist ever to become British National Paracycling Circuit Race Champion. He had previously won both a Sports Scholarship and a Vice Chancellor's Excellence Scholarship at the University of Exeter, and graduated from his double degree in Law and French Law last year.

He was born a normal weight, but throughout his childhood and teenage years lost all the fat around his face and limbs. His hearing deteriorated throughout his childhood, and he now wears hearing aids.

Researchers identify the single genetic mutation responsible for rare condition in UK Paracycling Champion, Tom Staniford. Credit: Tom Staniford

Tom's condition means he has no natural cushioning on his body, and suffers extremely sore feet and a higher risk of breaking bones if he falls from his bike. He has to take extra measures to protect himself from the cold, particularly when he races, and he boosts his energy levels through a special diet.

Unusually, Tom's body thinks he is obese because of the higher fat levels in his blood, and he has ; his diabetes is managed using metformin and a carefully controlled diet. However, when training, Tom is able to reduce his use of metformin as the intense exercise acts as form of self-medication, controlling his insulin levels.

Professor Andrew Hattersley, a Wellcome Trust Senior Investigator at the University of Exeter Medical School, has been working with Tom for several years, to help manage and understand his condition. He led an international team of researchers in a study of four unrelated patients in the UK, US and India, all with the same symptoms. None of the patients had any family history of a similar condition, suggesting that their condition may have been caused by individual – spontaneous changes in their DNA, rather than inherited mutations.

By sequencing and comparing the entire genomes of the patients and their families – the complete map of DNA in their bodies – Professor Hattersley and colleagues were able to pinpoint the exact mutation responsible – an abnormality in the POLD1 gene on chromosome 19. They found that a single amino acid was missing from an enzyme which is crucial to DNA replication. Recent studies have shown that a different type of mutation in the same gene is associated with a predisposition to colorectal and endometrial cancer.

Professor Hattersley says: "Tom's condition has been a puzzle to us for many years. We could see the symptoms, including the very unusual case of type 2 diabetes in someone with no obvious body fat, but did not know what was causing them.

"We had to look at thirty million base pairs in Tom's DNA, and similar numbers in his family members and the other patients, to identify the single mutation. This would not have been feasible even a couple of years ago, but new sequencing technology makes it possible for even patients with a rare genetic disorder to receive a diagnosis.

"Identifying the gene responsible has implications both for predicting the long term impact of the condition on Tom's health and – equally importantly to him – on his sporting career."

The diagnosis of MDP Syndrome has been as important to Tom for identifying what the disease is not as to what it is: he had previously been told by a specialist that he may have progeria, a rare genetic disorder of extreme premature ageing, associated with high risk of dementia. The new diagnosis will reassure Tom that this is not the case.

Professor Hattersley and colleagues hope that the genetic discovery will help scientists identify therapies that could make a significant difference for people with this rare and complex syndrome. It could also have wider implications for understanding obesity and related conditions; knowing how the body works when no fat is stored in key places can provide meaningful clues about why and how too much fat is stored.

Dr Michael Dunn, Head of Genetic and Molecular Sciences at the Wellcome Trust, adds: "This is a great example of coming of age. Where previously sequencing a patient's entire genome was prohibitively expensive, it is now far more cost effective. As we've seen here, it is no longer just about identifying genes implicated in common diseases, but is about informing diagnoses and prognoses of rare diseases – and, in Tom's case, helping inform his sporting performance."

Explore further: Rare genetic disorder provides clues to development of the pancreas

More information: Weedon, MN et al. An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy. Nature Genetics; 16 Jun 2013. DOI: 10.1038/ng.2670

Related Stories

Rare genetic disorder provides clues to development of the pancreas

December 11, 2011
A rare genetic disorder has given researchers at the University of Exeter a surprising insight into how the pancreas develops. The finding provides a clue to how it may be possible to 'programme' stem cells – master ...

Studies in mice confirm that mutations in the gene, UBE3B, cause a rare genetic disorder in children

November 29, 2012
Researchers have defined the gene responsible for a rare developmental disorder in children. The team showed that rare variation in a gene involved in brain development causes the disorder. This is the first time that this ...

Scientists identify genetic mutation behind rare disease

January 4, 2013
(Medical Xpress)—Researchers from Queen Mary, University of London, and Barts Health NHS Trust have identified the genetic mutation behind a devastating disease of the small intestine.

Genetic mutation inherited from father's side linked to early puberty

June 5, 2013
Reaching puberty at an unusually early age can have adverse effects on social behavior and psychological development, as well as physical effects, including short stature, and lifelong health risks, such as diabetes, breast ...

New discovery shows genetic causes of rare bone condition

January 29, 2013
(Medical Xpress)—Researchers at the University of Oxford have discovered two new genetic causes of craniosynostosis, a rare bone condition that can inhibit brain growth in children.

Sequencing of 500 genomes brings personalized medicine closer

August 4, 2011
The genomes of 500 people with a range of diseases – including cancer, immunological disorders, and rare inherited diseases – are to be sequenced in full detail thanks to a new collaboration between the ...

Recommended for you

Scientists provide insight into genetic basis of neuropsychiatric disorders

July 21, 2017
A study by scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) is providing insight into the genetic basis of neuropsychiatric disorders. In this research, the first mouse model of a mutation ...

Scientists identify new way cells turn off genes

July 19, 2017
Cells have more than one trick up their sleeve for controlling certain genes that regulate fetal growth and development.

South Asian genomes could be boon for disease research, scientists say

July 18, 2017
The Indian subcontinent's massive population is nearing 1.5 billion according to recent accounts. But that population is far from monolithic; it's made up of nearly 5,000 well-defined sub-groups, making the region one of ...

Mutant yeast reveals details of the aberrant genomic machinery of children's high-grade gliomas

July 18, 2017
St. Jude Children's Research Hospital biologists have used engineered yeast cells to discover how a mutation that is frequently found in pediatric brain tumor high-grade glioma triggers a cascade of genomic malfunctions.

Late-breaking mutations may play an important role in autism

July 17, 2017
A study of nearly 6,000 families, combining three genetic sequencing technologies, finds that mutations that occur after conception play an important role in autism. A team led by investigators at Boston Children's Hospital ...

Newly identified genetic marker may help detect high-risk flu patients

July 17, 2017
Researchers have discovered an inherited genetic variation that may help identify patients at elevated risk for severe, potentially fatal influenza infections. The scientists have also linked the gene variant to a mechanism ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.